SPPL2A and Alzheimer disease: To prioritize candidate causal variants in myeloid enhancers we selected loci where we discovered significant associations between chromatin activity, gene expression and AD risk (i.e. BIN1, GPR141, MS4A, PILRA, RABEP1, SPI1, SPPL2A, TP53INP1, and ZYX).